title: [Modified insulin treatment of therapy refractory schizophrenic disorders].
abstract: Subliminal hypoglycemia therapy (subcoma therapy, modified insulin therapy) is rarely practised in modern psychiatry. This study reports on the therapy of 105 patients (2619 single treatments) suffering from therapy-resistant schizophrenia. Evaluation was retrospective. Remarkably, 46.7% of the patients responded positively to a 4-6 week course of insulin therapy. In 26.6%, the effect was moderate. Tolerance ist good.
authors: Klinik für Psychiatrie, Universität Münster.
authors: B
authors: B
authors: Ruhwinkel
authors: R
authors: R
authors: Tölle
mesh_terms: D000328:Adult; D002908:Chronic Disease; D003295:Convulsive Therapy / Q000379:methods*; D003674:Defense Mechanisms; D005260:Female; D005500:Follow-Up Studies; D006760:Hospitalization; D006801:Humans; D008297:Male; D012189:Retrospective Studies; D012559:Schizophrenia / Q000628:therapy*; D012565:Schizophrenic Psychology
vernacular_title: Die "kleine" Insulinbehandlung bei therapieresistenten schizophrenen Störungen.